Therapy Areas: Oncology
Zymo wins CE IVD Mark for EZ DNA Methylation-Lightning Kit with bisulfite technology for clinical applications
23 September 2021 -

Scientific tool company Zymo Research reported on Thursday the receipt of the CE IVD Mark for its EZ DNA Methylation-Lightning Kit for distribution within the European Union (EU) common market for clinical diagnostic and screening tests of diseases.

The company said the EZ DNA Methylation-Lightning Kit features a ready-to-use conversion reagent, which streamlines the workflow for completion in a little over an hour. The kit is available in spin-column and high-throughput 96-well formats.

According to the company, the chemical treatment of DNA with bisulfite is the prerequisite for many methylation-based diagnostic assays. Clinical diagnostic and screening tests in cancer and developmental diseases are utilizing methylation profiling of DNA to detect the presence of disease and guide treatment.

In addition, the desulphonation and cleanup of converted DNA are performed using unique spin technology, allowing ultra-low elution (10 µl) volumes. The kit achieves the highest conversion efficiencies for the most accurate downstream methylation analysis, said the company.

Login
Username:

Password: